Text Size

Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00483795
First received: June 1, 2007
Last updated: July 23, 2007
Last verified: July 2007
History of Changes
  Purpose

To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.


Condition Intervention Phase
Corneal Staining
 Drug: sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Innovative Medical:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Patients 18 yrs or older
  • Males or females
  • Any race or ethnic background
  • CL patients using (multipurpose solutions) MPS
  • Patients using Acuvue 2 lenses

Exclusion Criteria:

  • Corneal refractive surgery within 6 months of this study.
  • Contact lens use on day of examination.
  • Corneal ectasia.
  • Current use of Restasis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00483795

Locations
United States, Pennsylvania
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States, 18202
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Thomas Kislan, OD Hazleton Eye Specialists
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00483795     History of Changes
Other Study ID Numbers: 5308
Study First Received: June 1, 2007
Last Updated: July 23, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Citric Acid
Anticoagulants
Hematologic Agents
Therapeutic Uses
 Pharmacologic Actions
Chelating Agents
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on May 23, 2013